Mapping of QLQ-C30 and QLQ-PR25 Scores to EQ-5D-5L Utility Values for Patients with Prostate Cancer Receiving Novel Androgen Receptor Signaling Inhibitors.

ABSTRACT:

Background and objective

Disease-specific questionnaires provide detailed health insights and are increasingly used in mapping studies to estimate utility values. Given the limited mapping studies in prostate cancer, our aim was to develop mapping algorithms to convert scores from disease-specific questionnaires to EQ-5D utility values for patients receiving novel androgen receptor signaling inhibitors (ARSIs).

Methods

This cross-sectional study enrolled prostate cancer patients in Taiwan. Health-related quality of life was assessed using the EQ-5D-5L, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30-item (QLQ-C30), and QLQ-Prostate Cancer 25-item (QLQ-PR25) instruments. Mapping algorithms were developed using ordinary least sq

SUBMITTER: Hao SY 

PROVIDER: S-EPMC12803998 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature